Elijah Brooks
About Elijah Brooks
Elijah Brooks is a GMP Cell Scientist at Marker Therapeutics, Inc. in Houston, Texas, with a strong educational background in microbiology, business administration, and public health from East Carolina University.
Work at Marker Therapeutics
Elijah Brooks has been employed at Marker Therapeutics, Inc. as a GMP Cell Scientist since 2021. In this role, he contributes to the development and production of cell therapies, ensuring compliance with Good Manufacturing Practices (GMP). His work is integral to advancing the company's mission in the field of immunotherapy. Marker Therapeutics is based in Houston, Texas, where Brooks applies his expertise in cell science to support innovative therapeutic solutions.
Education and Expertise
Elijah Brooks holds a Bachelor of Science in Microbiology from East Carolina University, which he completed from 2014 to 2018. He furthered his education by obtaining a Master of Public Health (MPH) in Health Services Administration from 2019 to 2020, followed by a Master of Business Administration (MBA) in Business Administration and Management from 2020 to 2021. This diverse educational background equips him with a comprehensive understanding of both scientific and business aspects of healthcare.
Background
Prior to his current position, Elijah Brooks worked as a Graduate Assistant at East Carolina University from 2019 to 2021. In this role, he gained valuable experience in research and academic support, contributing to his professional development in the field of microbiology and public health. His academic and professional journey reflects a commitment to advancing his knowledge and skills in both scientific research and healthcare management.
Achievements
Elijah Brooks has achieved significant academic qualifications, including a Bachelor of Science in Microbiology, a Master of Public Health, and a Master of Business Administration. His educational accomplishments demonstrate a strong foundation in both the scientific and administrative aspects of healthcare. His role as a GMP Cell Scientist at Marker Therapeutics further highlights his expertise in cell therapy production and compliance with industry standards.